Michael McLaughlin is a skilled leader in program management and clinical operations with extensive experience in the pharmaceutical and biotech sectors. Previously, they held significant roles at GlaxoSmithKline, Cato Research, and Dermavant Sciences, where they successfully managed drug development processes and led teams to achieve critical milestones, including NDA approvals. Currently, Michael is the Director of Program Management at Immunovant and pursuing multiple advanced degrees in health science and therapeutic recreation. Their expertise in establishing strategic frameworks and strengthening business partnerships greatly contributes to organizational success in drug development.
This person is not in any teams
This person is not in any offices